CLINDAMYCIN INJECTION IN 5% DEXTROSE
Google image searchProduct monograph
Active ingredient
clindamycin (clindamycin phosphate), 600 MG/50 ML
DIN: 02485478
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: BAXTER CORPORATION
Date: 26-NOV-2019
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01F — MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS (ATC, ATC/DDD)
- J01FF — Lincosamides (ATC, ATC/DDD)
- J01FF01 — CLINDAMYCIN (ATC/DDD)
Reference brand drug: Dalacin C
Pharmaceutical standard: MFR
